Update on deep brain stimulation for neuropsychiatric disorders

Neurobiology of Disease

Volumn 38, Issue 3, 2010, Pages 346-353

  Ward, Herbert E ^a   Hwynn, Nelson ^b   Okun, Michael S ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Deep brain stimulation; Depression; Neuropsychiatric; OCD; Tourette

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BOTULINUM TOXIN; CLOMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

BRAIN DEPTH STIMULATION; BRAIN SURGERY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; GILLES DE LA TOURETTE SYNDROME; HUMAN; MENTAL DISEASE; NERVE CELL NETWORK; NEUROMODULATION; OBSESSIVE COMPULSIVE DISORDER; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; STEREOTAXIC SURGERY; THERAPY EFFECT; THERAPY RESISTANCE; TREATMENT OUTCOME;

DEEP BRAIN STIMULATION; HUMANS; MENTAL DISORDERS;

EID: 77952545533     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.01.011     Document Type: Review

References (106)

1. Abelson J.L., Curtis G.C., Sagher O., Albucher R.C., Harrigan M., Taylor S.F., Martis B., Giordani B. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol. Psychiatry 2005, 57(5):510-516. Mar 1.
2. Abosch A., Cosgrove G.R. Biological basis for the surgical treatment of depression. Neurosurg. Focus 2008, 25(1):1-12.
3. Ackermans L., Temel Y., Cath D., van der Linden C., Bruggeman R., Kleijer M., Nederveen P., Schruers K., Colle H., Tijssen M.A., Visser-Vandewalle V. Deep brain stimulation in Tourette's syndrome: two targets. Mov. Disord. 2006, 21(5):709-713. Dutch Flemish Tourette Surgery Study Group, May.
4. Albert U., Bergesio C., Pessina E., Maina G., Bogetto F. Management of treatment resistant obsessive-compulsive disorder: algorithms for pharmacotherapy. Panminerva Med. 2002, 44:83-91.
5. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
6. Aouizerate B., Cuny E., Martin-Guehl C., Guehl D., Amieva H., Benazzouz A., Fabrigoule C., Allard M., Rougier A., Bioulac B., Tignol J., Burbaud P. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J. Neurosurg. 2004, 101(4):682-686. Oct.
7. Ardouin C., Pillon B., Peiffer E., Bejjani P., Limousin P., Damier P., Arnulf I., Benabid A.L., Agid Y., Pollack P. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann. Neurol. 1999, 46:217-223.
8. Bajwa R.J., de Lotbinière A.J., King R.A., Jabbari B., Quatrano S., Kunze K., Scahill L., Leckman J.F. Deep brain stimulation in Tourette's syndrome. Mov. Disord. 2007, 22(9):1346-1350. Jul 15.
9. Bebbington P.E. Epidemiology of obsessive-compulsive disorder. Br. J. Psychiatry 1998, 35(Suppl.):2-6.
10. Benabid A.L., Pollack P., Seigneuret E., Hoffmann D., Gay E., Perret J. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir. Suppl. (Wien). 1993, 58:39-44.
11. Benabid A.L., Benazzouz A., Hoffmann D., Limousin P., Krack P., Pollak P. Long-term electrical inhibition of deep brain targets in movement disorders. Mov. Disord. 1998, 13(3):119-125.
12. Bingley T., Leksell L., Meyerson B.A. Long term results of stereotactic anterior capsulotomy in chronic obsessive-compulsive neurosis. Neurosurgical Treatment in Psychiatry, Pain, and Epilepsy 1977, 287-299. University Park Press, Baltimore. W.H. Sweet, S. Obrador, J.G. Martin-Rodriquez (Eds.).
13. Carr J.E., Chong I.M. Habit reversal treatment of tic disorders: a methodological critique of the literature. Behav. Modif. 2005, 29:858-875.
14. Cif L., El Fertit H., Vayssiere N., Hemm S., Hardouin E., Gannau A., Tuffery S. and P. Coubes: treatment of dystonic syndromes by chronic electrical stimulation of the internal globus pallidus. J. Neurosurg. Sci. 2003, 47:52-55.
15. Cosgrove G.R., Rauch S. Stereotactic cingulotomy. Neurosurg. Clin. N. Am. 2003, 14:225-235.
16. Cosyns P., Gabriels L.A., Nuttin B.J. Deep brain stimulation in treatment refractory obsessive compulsive disorder. Verh. K. Acad. Geneeskd. Belg. 2003, 65(6):385-399. discussion 399-400.
17. Coubes P., Roubertie A., Vayssiere N., Hemm S., Exhenne B. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000, 355:2220-2221.
18. Coubes P., Cif L., El Fertit H., Hemm S., Vayssiere N., Serrat S., Picot M.C., Tuffery S., Claustres M., Echenne B., Frerebeau P. Electrical stimulation of the globus pallidus intermus in patients with primary generalized dystonia: long-term results. J. Neurosurg. 2004, 101:189-194.
19. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993, 50:873-880.
20. Dehning S., Mehrkens J.H., Müller N., Bötzel K. Therapy-refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulation. Mov. Disord. 2008, 23(9):1300-1302. Jul 15.
21. Deijsers G., Hoogduin C., Shaap C. Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br. J. Psychiatry 1994, 165:781-786.
22. Denys D., Van Der Wee N., Van Megen H.J., Westenberg H.G. A double-blind comparison of venlafaxine and paroxetine in obsessvie-compulsive disorder. J. Clin. Psychopharmacol. 2003, 23:568-575.
23. DeVeaugh-Geiss, Katz R., Landau P., Goodman W., Rasmussen S. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol. Bull. 1990, 26:54-59.
24. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition ed. 2000, American Psychiatric Association, Washington, DC.
25. Diederich N.J., Kalteis K., Stamenkovic M., Pieri V., Alesch F. Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Mov. Disord. 2005, 20(11):1496-1499. 2005 Nov.
26. Dougherty D.D., Rauch S.L., Jenike M.A. Pharmacological treatments for obsessive compulsive disorder. A Guide to Treatments that Work 2002, 387-410. Oxford University Press, London, UK. 2nd ed. P.E. Nathan, J.M. Gorman (Eds.).
27. Dunner D.L., Rush A.J., Russell J.M., Burke M., Woodard S., Wingard P., Allen J. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment resistant depression. J. Clin. Psychiatry 2006, 67:688-695.
28. Erenberg G., Cruse R., Rothner A. The natural history of Tourette syndrome: a follow-up study. Ann. Neurol. 1987, 22:383-385.
29. Flaherty A.W., Williams Z.M., Amirnovin R., Kasper E., Rauch S.L., Cosgrove G.R., Eskandar E.N. Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005, Oct;57(4 Suppl.):E403; discussion E403.
30. Fontaine D., Mattei V., Borg M., von Langsdorff D., Magnie M.N., Chanalet S., Robert P., Paquis P. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report. J. Neurosurg. 2004, 100(6):1084-1086. Jun.
31. Gabriels L., Cosyns P., Nuttin B., Demeulemeester H., Gybels J. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatry Scand. 2003, 107(4):275-282. Apr.
32. Gagne G.G., Furman M.J., Carpenter L.L., Price L.H. Efficacy of continuation ECT and antidepressant drugs compared to long term antidepressants alone in depressed patients. Am. J. Psychiatry 2000, 157:1960-1965.
33. Gao O.K., Muzina D., Gajwani P., Calabrese J.R. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J. Clin. Psychiatry 2005, 67(9):1327-1340.
34. Goodman W.K., Price L.H., Rasmussen S.A., et al. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Arch. Gen. Psychiatry 1989, 46:1006-1011.
35. Goodman W., McDougle C., Barr L., Aronson S., Price L. Biological approaches to treatment-resistant obsessive compulsive disorder. J. Clin. Psychiatry 1993, 54(Suppl.):16-26.
36. Greenberg B.D., Murphy D.L., Rasmussen S.A. Neuroanatomically based approaches to obsessive-compulsive disorder: neurosurgery and transcranial magnetic stimulation. Psychiatry. Clin. N. Am. 2000, 23:671-686.
37. Greenberg B.D., Price L.H., Rauch S.L., Friehs G., Noren G., Malone D. et al.: Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg. Clin. N. AM. 2003, 14:199-212.
38. Greenberg B.D., Malone D.A., Friehs G.M., Rezai A.R., Kubu C.S., Malloy P.F., Salloway S.P., Okun M.S., Goodman W.K., Rasmussen S.A Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006, 31:2384-2393.
39. Hamilton M. Rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-61.
40. Hauptman J.S., De Salles A.A.F., Espinoza R., Sedrak M.S., Ishida W. Potential surgical targets for deep brain stimulation in treatment-resistant depression. Neurosurg. Focus. 2008, 25(1):1-9.
41. Houeto J.L., Karachi C., Mallet L., Pillon B., Yelnik J., Mesnage V., Welter M.L., Navarro S., Pelissolo A., Damier P., Pidoux B., Dormont D., Cornu P., Agid Y. Tourette's syndrome and deep brain stimulation. J. Neurol. Neurosurg. Psychiatry 2005, 76(7):992-995. Jul.
42. Jankovic J. Recent advances in the management of tics. Clin. Neuropharmacol. 1986, 9(Suppl. 2):S100-110.
43. Jenike M.A. Neurosurgical treatment of obsessive-compulsive disorder. Br. J. Psychiatry 1998, 173(Suppl. 35):79-90.
44. Jenike M.A., Baer L., Ballantine T., Martuza R.I., Tynes S., Giriunas I., Buttolph M.L., Cassem N.H. Cingulotomy for refradtory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch. Gen. Psychiatry 1991, 48:548-555.
45. Jiménez F., Velasco F., Salín-Pascual R., Velasco M., Nicolini H., Velasco A.L., Castro G. Neuromodulation of the inferior thalamic peduncle for major depression and obsessive compulsive disorder. Acta Neurochir. Suppl. 2007, 97(Pt. 2):393-398.
46. Karno M., Goldin J.M., Sorenson S.B., Burnam M.A. The epidemiology of obsessive compulsive disorder in five US communities. Arch. Gen. Psychiatry 1988, 45:1094-1099.
47. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
48. Keuneman R., Pokos V., Weerasundera R., Castle D.J. Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Aust. N.Z. J. Psychiatry 2005, 39:336-343.
49. Kopell B.H., Greenberg B.D. Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry. Neurosci. Biobehav. Rev. 2008, 32:408-422.
50. Koran L.M., Thienemann M.L., Davenport R. Quality of life for patients with obsessive-compulsive disorder. Am. J. Psychiatry 2006, 153:783-788.
51. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., Koudsie A., Limousin P.D., Benazzouz A., LeBas J.F., Benabid A.L., Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 2003, 349:1925-1934.
52. Kumar R., Lang A.E., Rodriquez-Oroz M.C., Lozano A.M., Limousin P., Pollak P., Benabid A.L., Guridi J., Ramos E., van der Linden C., Vandewalle A., Caemaert J., Lannoo E., van den Abbeele D., Vingerhoets G., Wolters M., Obeso J.A. Deep brain stimulation of the globus pallidus par interna in advanced Parkinson's disease. Neurology 2000, 55:S34-S39.
53. Kurlan R. Tourette syndrome. Treatment of tics. Neurol. Clin. 1997, 15:403-409.
54. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz A.L., Stevenson J., Cohen D.J. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Clild. Adolesc. Psychiatry 1989, 28:566-573.
55. Leckman J., Zhang H., Vitale A., Lahnin F., Lynch K., Bondi C., Kim Y.S., Peterson B.S. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998, 102:14-19.
56. Lipsman N., Neimat J.S., Lozano A.M. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target. Neurosurgery 2007, 61:1-13.
57. Lopez A.D., Murray C.C. The global burden of disease, 1990-2020. Nat. Med. 1998, 4:1241-1243.
58. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
59. Lozano A.M., Mahant N. Deep brain stimulation surgery for Parkinson's disease: mechanisms and consequences. Parkinsonism Relat. Disord. 2004, 10(Suppl.1):S49-S57.
60. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C., Kennedy S.H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 2008, 64(6):461-467. Sep 15.
61. Lyons K.E., Pahwa R. Deep brain stimulation and essential tremor. J. Clin. Neurophysiol. 2004, 21:2-5.
62. Maciunas R.J., Maddux B.N., Riley D.E., Whitney C.M., Schoenberg M.R., Ogrocki P.J., Albert J.M., Gould D.J. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. J. Neurosurg. 2007, 107(5):1004-1014. Nov.
63. Malone D.A., Dougherty D.D., Rezai A.R., Carpenter L.L., Friehs G.M., Eskandar E.N., Rauch S.L., Rasmussen S.A., Machado A.G., Kubu C.S., Tyrka A.R., Price L.H., Stypulkowski P.H., Giftakis J.E., Rise M.T., Malloy P.F., Salloway S.P., Greenberg B.D. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry 2009, 65(4):267-275.
64. March J.S., Frances A., Carpenter D., Kahn D. Treatment of obssessive-compulsive disorder. The Expert Consesnus Panel for Obsessive-Compulsive Disorder. J. Clin. Psychiatry 1997, 58(suppl.):1-72.
65. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neurospsychiatry Clin. Neurosci. 1997, 9:471-481.
66. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimized treatment. Br. Med. Bull. 2003, 65:193-207.
67. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
68. Miguel E.C., do Rosario-Campos M.C., Prado H.S., et al. Sensory phenomena in obsessive-compulsive disorder and Tourette disorder. J. Clin. Psychiatry 2000, 61:150-156.
69. Mindus P., Meyerson B. Anterior capsulotomy for intractable anxiety disorders. Operative Neurosurgical Techniques, Indications, Methods and Results 1995, 1413-1421. W.B. Saunders Company, Philadelphia. 3rd Edn. H. Schmidek, W. Sweet (Eds.).
70. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 1996, 50:381-425.
71. Mink J.W. Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?. Adv. Neurol. 2001, 85:113-122.
72. Mink J.W. Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. Adv. Neurol. 2006, 99:89-98.
73. Mink J.W., Walkup J., Frey K.A., Como P., Cath D., DeLong M.R., Erenberg G., Jankovic J., Juncos J., Leckman J.F., Swerdlow N., Visser-Vandewalle V., Vitek J.L. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov. Disord. 2006, 21:1831-1838. Tourette Syndrome Association, Number 11.
74. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosci. 1989, 1:27-36.
75. Nuttin B.J., Gabriels L.A., Cosyns P.R., Meyerson B.A., Andréewitch S., Sunaert S.G., Maes A.F., Dupont P.J., Gybels J.M., Gielen F., Demeulemeester H.G. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 2003, 52(6):1263-1272. Jun discussion 1272-4.
76. Oliver B., Gascon J., Aparicio A., Ayats E., Rodriguez R., Maestro De Leon J.L., Garcia-Bach, M., Soler P.A. Bilateral anterior capsulotomy for refractory obsessive-compulsive disorders. Stereotact. Funct. Neurosurg. 2003, 81:90-95.
77. Olson S. Neurobiology: making sense of Tourette's. Science 2004, 305:1390-1392.
78. Parent A., Carpenter M.B. Carpenter's Human Neuroanatomy 1996, Williams and Wilkins, Baltimore.
79. Plewnia C., Schober F., Rilk A., Buchkremer G., Reimold M., Wächter T., Bruit S., Weiss D., Kruger R., Feuerstein D. Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophrenia. Into. J. Neuropsychopharmacol. 2008, 13:1-3. Aug.
80. Pollak P., Fraix V., Krack P., Moro E., Mendes A., Chabardes S., Koudsie A., Benabid A.L. Treatment results: Parkinson's disease. Mov. Disord. 2002, 17(Suppl 3):S75-83.
81. Rampello L., Alvano A., Battaglia G., Bruno V., Raffaele R., Nicoletti F. Tic disorders: from pathophysiology to treatment. J. Neurol. 2006, 253:1-15.
82. Rasmussen S.A., Eisen J.L. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatry Clin. North. Am. 1992, 15:743-758.
83. Rasmussen S.A., Eisen J.L. Treatment strategies for chronic and refractory obsessive-compulsive disorder. J. Clin. Psychiatry 1997, 58:9-13.
84. Rauch S.L., Jenike M.A. Neurobiological models of obsessive-compulsive disorder. Psychosomatics 1993, 34:20-32.
85. Rauch S.L., Baer L., Cosgrove G.R., Jenike M.A. Neurosurgical treatment of Tourette's syndrome: a critical review. Compr. Psychiatry 1995, 36:141-156.
86. Robertson M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123:425-462.
87. Rosenow J.M., Mogilnert A.Y., Ahmed A., Rezai A.R. Deep brain stimulation for movement disorders. Neurol. Res. 2004, 26:9-20.
88. Ruo B., Rumsfeld J.S., Hlatky M.A., Liu H., Browner W.S., Whooley M.A. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003, 290:215-221.
89. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 2006, 163(11):1905-1917.
90. Scahill L.D., Leckman J.F., Marek K.L. Sensory phenomena in Tourette syndrome. Adv. Neurol. 1995, 65:273-280.
91. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., Joe A.Y., Kreft M., Lenartz D., Sturm V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33:368-377.
92. Schulz R., Beach S.R., Ives D.B., Martire L.M., Aryo A.A., Kop W.J. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch. Intern. Med. 2000, 160:1761-1768.
93. Servello D., Porta M., Sassi M., Brambilla A., Robertson M.M. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J. Neurol. Neurosurg. Psychiatry 2008, 79(2):136-142. Feb.
94. Shahed J., Poysky J., Kenney C., Simpson R., Jankovic J. GPi deep brain stimulation for Tourette Syndrome improves tics and psychiatric comorbidities. Neurology 2007, 68(2):159-160. Jan 9.
95. Singer H.S., Minzer K. Neurobiology of Tourette syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev. 2003, 25(Supppl. 1):S70-S84.
96. Singer H.S., Walkup J.T. Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment. Medicine 1991, 70:15-32. Baltimore.
97. Stein M.B., Forde D.R., Anderson G., Walker J.R. Obsessive-compulsive disorder in the community: an epidemiological survey with clinical reappraisal. Am. J. Psychiatry 1997, 154:1120-1126.
98. Stern J.S., Burza S., Robertson M.M. Filles de la Tourette syndrome and its impact in the UK. Post. grad. Med. 2005, 81:12-19.
99. Synofzik M., Schalaepfer T.E. Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol. J. 2008, 3:1511-1520.
100. Temel Y., Visser-Vanderwalle V. Surgery in Tourette syndrome. Mov. Disord. 2004, 19:3-14.
101. Van Melle J.P., de Jong P., Spikerman T.A., Tijssen J.B., Ormel J., van Veldhuisen D.J., van den Brink R.H., van den Berg M.P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom. Med. 2004, 66:814-822.
102. Visser-Vandewalle V., Temel Y., van der Linden C., Ackermans L., Beuls E. Deep brain stimulation in movement disorders. The applications reconsidered. Acta Neurol. Belg. 2004, 104:33-36.
103. Weissman M.M., Bland R.C., Canino G.J., Greenwald S., Hwu H.G., Joyce P.R., Karam E.G., Lee C.K., Lellouch J., Lepine J.P., Newman S.C., Rubio-Stipec M., Wells J.E., Wickramaratne P.J., Wittchen H.U., Yeh E.K. Prevalence of suicide ideation and suicide attempts in nine countries. Psychol. Med. 1999, 29:9-17.
104. Welter M.L., Mallet L., Houeto J.L., Karachi C., Czernecki V., Cornu P., Navarro S., Pidoux B., Dormont D., Bardinet E., Yelnik J., Damier P., Agid Y. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch. Neurol. 2008, 65(7):952-957. Jul.
105. Wiener J.M. Psychopharmacology in childhood disorders. Psychiatric Clin. North Am. 1984, 7:831-843.
106. Woerdeman P.A., Willems P.W., Noordmans H.J., Berkelbach van der Sprenkel J.W., van Rijen P.C. Frameless stereotactic subcaudate tractotomy for intractable obsessive-compulsive disorder. Acta Neurochir. (Wien). 2006, 148:633-637.